We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
-5.8%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$17.9B
AUM Growth
-$2.38B
(-12%)
Cap. Flow
-$772M
Cap. Flow
% of AUM
-4.31%
Top 10 Holdings %
Top 10 Hldgs %
23.3%
Holding
1,751
New
15
Increased
221
Reduced
786
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verra Mobility
VRRM
|
+$34.1M |
| 2 |
S&P Global
SPGI
|
+$22.9M |
| 3 |
Quanta Services
PWR
|
+$22M |
| 4 |
NOVA
Sunnova Energy
NOVA
|
+$20.8M |
| 5 |
Johnson Controls International
JCI
|
+$19.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LTHM
Livent Corporation
LTHM
|
+$54.7M |
| 2 |
IPG Photonics
IPGP
|
+$48.9M |
| 3 |
Darling Ingredients
DAR
|
+$46.6M |
| 4 |
NVIDIA
NVDA
|
+$45.2M |
| 5 |
Amazon
AMZN
|
+$38.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.99% |
| 2 | Healthcare | 18.87% |
| 3 | Consumer Discretionary | 13.32% |
| 4 | Financials | 12.03% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
M/I Homes
MHO
$3.88B
| $310K | ﹤0.01% |
7,000
| – | – |
|
|
PRO
1502
DELISTED
PROS Holdings
PRO
| $310K | ﹤0.01% |
9,300
| – | – |
|
1503
PennyMac Financial
PFSI
$4.12B
| $309K | ﹤0.01% |
5,800
-1,500
| -21% | -$90.7K |
|
1504
Regenxbio
RGNX
$707M
| $309K | ﹤0.01% |
9,300
| – | – |
|
1505
Andersons Inc
ANDE
$2.23B
| $308K | ﹤0.01% |
6,123
-2,500
| -29% | -$105K |
|
1506
B&G Foods
BGS
$298M
| $307K | ﹤0.01% |
11,388
| – | – |
|
1507
World Acceptance Corp
WRLD
$891M
| $307K | ﹤0.01% |
1,600
| – | – |
|
1508
ArcBest
ARCB
$3.24B
| $306K | ﹤0.01% |
3,800
| – | – |
|
1509
Enanta Pharmaceuticals
ENTA
$407M
| $306K | ﹤0.01% |
4,300
-2,200
| -34% | -$143K |
|
1510
AdaptHealth
AHCO
$772M
| $305K | ﹤0.01% |
19,000
| – | – |
|
1511
Hain Celestial
HAIN
$54.3M
| $304K | ﹤0.01% |
8,839
-9,100
| -51% | -$331K |
|
1512
Celldex Therapeutics
CLDX
$3.44B
| $303K | ﹤0.01% |
8,900
| – | – |
|
1513
Vir Biotechnology
VIR
$1.54B
| $303K | ﹤0.01% |
11,800
+600
| +5% | +$17.8K |
|
1514
Usana Health Sciences
USNA
$258M
| $302K | ﹤0.01% |
3,800
| – | – |
|
|
NSTG
1515
DELISTED
NanoString Technologies, Inc.
NSTG
| $302K | ﹤0.01% |
8,700
-2,000
| -19% | -$68.9K |
|
|
FOCS
1516
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $302K | ﹤0.01% |
6,600
-4,000
| -38% | -$201K |
|
1517
Adaptive Biotechnologies
ADPT
$3.96B
| $300K | ﹤0.01% |
21,600
| – | – |
|
1518
Codexis
CDXS
$176M
| $299K | ﹤0.01% |
14,500
| – | – |
|
1519
Cimpress
CMPR
$2.36B
| $299K | ﹤0.01% |
4,700
| – | – |
|
1520
Virgin Galactic
SPCE
$463M
| $297K | ﹤0.01% |
1,505
| – | – |
|
1521
Globalstar
GSAT
$10.8B
| $296K | ﹤0.01% |
13,413
-4,747
| -26% | -$80.7K |
|
1522
Twist Bioscience
TWST
$7.8B
| $296K | ﹤0.01% |
6,000
-2,900
| -33% | -$161K |
|
|
IRBT
1523
DELISTED
iRobot
IRBT
| $295K | ﹤0.01% |
4,658
| – | – |
|
1524
La-Z-Boy
LZB
$1.67B
| $295K | ﹤0.01% |
11,202
| – | – |
|
1525
AppFolio
APPF
$6.92B
| $294K | ﹤0.01% |
2,600
-1,200
| -32% | -$138K |
|
Similar funds
VIA
Handelsbanken Fonder's Q1 2022 Portfolio in Review
As of Q1 2022, Handelsbanken Fonder held 1,751 positions worth $17.9B, down 12% from $20.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Handelsbanken Fonder withdrew a net $772M in Q1 2022, closing 51 positions and reducing 786 holdings. Its most notable exit was IHS Markit Ltd. Common Shares, an estimated $13.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Handelsbanken Fonder opened a new position in Johnson Controls International worth $18.5M.
- Handelsbanken Fonder's largest Q1 2022 buy was Johnson Controls International: 282,551 shares worth $18.5M.
- Handelsbanken Fonder added most to Verra Mobility in Q1 2022, an estimated $34.1M increase.
- Handelsbanken Fonder's biggest Q1 2022 reduction was Livent Corporation, cutting an estimated $54.7M.
- Handelsbanken Fonder fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $13.8M.
- Handelsbanken Fonder's ten largest holdings make up 23% of its $17.9B portfolio in Q1 2022.
- Handelsbanken Fonder opened 15 new positions and closed 51 in Q1 2022.
- Handelsbanken Fonder's portfolio value fell 12% quarter-over-quarter to $17.9B.
Based on Handelsbanken Fonder's 13F filing for Q1 2022, filed 11 May 2022.